Mechanical strain triggers endothelial-to-mesenchymal transition of the endocardium in the immature heart.
Pediatr Res
; 92(3): 721-728, 2022 09.
Article
en En
| MEDLINE
| ID: mdl-34837068
ABSTRACT
BACKGROUND:
Endothelial-to-mesenchymal-transition (EndMT) plays a major role in cardiac fibrosis, including endocardial fibroelastosis but the stimuli are still unknown. We developed an endothelial cell (EC) culture and a whole heart model to test whether mechanical strain triggers TGF-ß-mediated EndMT.METHODS:
Isolated ECs were exposed to 10% uniaxial static stretch for 8 h (stretch) and TGF-ß-mediated EndMT was determined using the TGF-ß-inhibitor SB431542 (stretch + TGF-ß-inhibitor), BMP-7 (stretch + BMP-7) or losartan (stretch + losartan), and isolated mature and immature rats were exposed to stretch through a weight on the apex of the left ventricle. Immunohistochemical staining for double-staining with endothelial markers (VE-cadherin, PECAM1) and mesenchymal markers (αSMA) or transcription factors (SLUG/SNAIL) positive nuclei was indicative of EndMT.RESULTS:
Stretch-induced EndMT in ECs expressed as double-stained ECs/total ECs (cells 46 ± 13%; heart 15.9 ± 2%) compared to controls (cells 7 ± 2%; heart 3.1 ± 0.1; p < 0.05), but only immature hearts showed endocardial EndMT. Inhibition of TGF-ß decreased the number of double-stained cells significantly, comparable to controls (cells/heart control 7 ± 2%/3.1 ± 0.1%, stretch 46 ± 13%/15 ± 2%, stretch + BMP-7 7 ± 2%/2.9 ± 0.1%, stretch + TGF-ß-inhibitor (heart only) 5.2 ± 1.3%, stretch + losartan (heart only) 0.89 ± 0.1%; p < 0.001 versus stretch).CONCLUSIONS:
Endocardial EndMT is an age-dependent consequence of increased strain triggered by TGF- ß activation. Local inhibition through either rebalancing TGF-ß/BMP or with losartan was effective to block EndMT. IMPACT Mechanical strain imposed on the immature LV induces endocardial fibroelastosis (EFE) formation through TGF-ß-mediated activation of endothelial-to-mesenchymal transition (EndMT) in endocardial endothelial cells but has no effect in mature hearts. Local inhibition through either rebalancing the TGF-ß/BMP pathway or with losartan blocks EndMT. Inhibition of endocardial EndMT with clinically applicable treatments may lead to a better outcome for congenital heart defects associated with EFE.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Fibroelastosis Endocárdica
/
Endocardio
Tipo de estudio:
Prognostic_studies
Límite:
Animals
Idioma:
En
Revista:
Pediatr Res
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos